Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Central nervous system disorder | x | |||||||||||||||||||
Cerebral palsy | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
Muscle spasms | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
Muscle spasticity | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Pain | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Spinal cord disorder | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | |||||
Tenderness | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |